Medicine and Dentistry
Allergic Encephalitis
50%
Encephalitis
39%
Immune Checkpoint Inhibitor
25%
Neurologic Disease
24%
Intensive Care Unit
19%
Neurology
16%
Magnetic Resonance Imaging
15%
Positron Emission Tomography-Computed Tomography
14%
Anti N Methyl D Aspartate Receptor Encephalitis
14%
Diagnosis
13%
Status Epilepticus
12%
Epileptic Seizure
12%
Disease
12%
Multiple Sclerosis
11%
Fluorodeoxyglucose
11%
Burnout
9%
Malignant Neoplasm
9%
Methylprednisolone
9%
Autoantibodies
8%
Retrospective Study
8%
Metastatic Carcinoma
8%
Immune-Related Adverse Events
7%
Autoimmunity
7%
Modified Rankin Scale
7%
Ketogenic Diet
7%
Brain Disease
6%
Nervous System
6%
Adverse Event
6%
Neurological Complication
5%
Virus Infection
5%
Differential Diagnosis
5%
Wellbeing
5%
Brain Metabolism
5%
Immunosuppressive Treatment
5%
Occipital Lobe
5%
Polyethylene Terephthalate
5%
Quality Improvement
5%
Neoplasm
5%
Neuroscience
Encephalitis
100%
Positron Emission Tomography-Computed Tomography
28%
Status Epilepticus
22%
NMDA Receptor
20%
Magnetic Resonance Imaging
18%
Fluorine-18
12%
Multiple Sclerosis
11%
Autoantibodies
11%
Ketogenic Diet
10%
Positron Emission Tomography
10%
Eicosanoid Receptor
10%
Electroencephalography
9%
Nervous System Disorder
8%
Behavior (Neuroscience)
8%
Occipital Lobe
7%
Methyldienolone
7%
Dextro Aspartic Acid
7%
Metabolic Pathway
7%
Electroencephalography
6%
Delirium
6%
Positron Emission Tomography
6%
Limbic Encephalitis
5%
Aspartic Acid
5%
Brain Metabolism
5%
Keyphrases
Autoimmune Encephalitis
55%
Encephalitis
28%
Immune Checkpoint Inhibitors
12%
Etiology
11%
New-onset Refractory Status Epilepticus (NORSE)
11%
18F-FDG PET-CT
10%
Multiple Sclerosis
10%
Anti-NMDAR Encephalitis
9%
Neurohospitalist
9%
Risk Score
9%
18F-fluorodeoxyglucose PET
9%
Neurology
9%
Intensive Care Unit
8%
Modified Rankin Scale
8%
Methylprednisolone
8%
Positron Emission Tomography-computed Tomography (PET-CT)
7%
Seronegative Autoimmune Encephalitis
7%
Neurological Examination
7%
Neurological Impairment
6%
Brain FDG-PET
6%
Hypermetabolism
6%
Paraneoplastic Syndrome
6%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
6%
Survivors
6%
Neurologic
6%
Immune-related Adverse Events
5%
Hypermetabolic
5%
Differential Diagnosis
5%
Metabolism
5%
Occipital Lobe
5%
Adaptive Behavior
5%
Neurologist
5%
New Diagnosis
5%
Hypometabolism
5%